253 related articles for article (PubMed ID: 27337847)
41. [Gouty kidney].
Hosoya T
Nihon Rinsho; 2003 Jan; 61 Suppl 1():230-4. PubMed ID: 12629723
[No Abstract] [Full Text] [Related]
42. Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
Riegersperger M; Covic A; Goldsmith D
Int Urol Nephrol; 2011 Jun; 43(2):441-9. PubMed ID: 21547469
[TBL] [Abstract][Full Text] [Related]
43. Genetic factors associated with gout and hyperuricemia.
Bleyer AJ; Hart TC
Adv Chronic Kidney Dis; 2006 Apr; 13(2):124-30. PubMed ID: 16580613
[TBL] [Abstract][Full Text] [Related]
44. Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived.
Viazzi F; Leoncini G; Ratto E; Pontremoli R
J Clin Hypertens (Greenwich); 2006 Jul; 8(7):510-8. PubMed ID: 16849905
[TBL] [Abstract][Full Text] [Related]
45. Uric acid and transplantation.
Mazzali M
Semin Nephrol; 2005 Jan; 25(1):50-5. PubMed ID: 15660335
[TBL] [Abstract][Full Text] [Related]
46. Uric acid and cardiovascular risk.
Feig DI; Kang DH; Johnson RJ
N Engl J Med; 2008 Oct; 359(17):1811-21. PubMed ID: 18946066
[No Abstract] [Full Text] [Related]
47. Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?
Gaffo AL; Edwards NL; Saag KG
Arthritis Res Ther; 2009; 11(4):240. PubMed ID: 19725932
[TBL] [Abstract][Full Text] [Related]
48. [Hyperuricemia and the metabolic syndrome].
Mitu F; Drăgan MV
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1001-5. PubMed ID: 20191866
[TBL] [Abstract][Full Text] [Related]
49. Hyperuricemia and adverse outcomes in cardiovascular disease: potential for therapeutic intervention.
Gavin AR; Struthers AD
Am J Cardiovasc Drugs; 2003; 3(5):309-14. PubMed ID: 14728064
[TBL] [Abstract][Full Text] [Related]
50. The role of uric acid in pediatric hypertension.
Feig DI; Johnson RJ
J Ren Nutr; 2007 Jan; 17(1):79-83. PubMed ID: 17198939
[TBL] [Abstract][Full Text] [Related]
51. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease.
Kang DH; Nakagawa T
Semin Nephrol; 2005 Jan; 25(1):43-9. PubMed ID: 15660334
[TBL] [Abstract][Full Text] [Related]
52. The perils of nontreatment of hyperuricemia.
Hoffman GS
Cleve Clin J Med; 1997 Apr; 64(4):215. PubMed ID: 9105118
[No Abstract] [Full Text] [Related]
53. [Impact of serum uric acid level on the cardiovascular system as a risk factor].
Hisatome I
Nihon Yakurigaku Zasshi; 2010 Dec; 136(6):325-9. PubMed ID: 21139282
[No Abstract] [Full Text] [Related]
54. Uric acid and the vasculature.
Corry DB; Tuck ML
Curr Hypertens Rep; 2006 May; 8(2):116-9. PubMed ID: 16672143
[TBL] [Abstract][Full Text] [Related]
55. [Relationship between hyperuricemia and metabolic syndrome].
Yamasaki T; Tomita K
Nihon Rinsho; 2008 Apr; 66(4):766-70. PubMed ID: 18409529
[TBL] [Abstract][Full Text] [Related]
56. Hyperuricemia, cardiovascular disease, and the metabolic syndrome.
Indraratna PL; Williams KM; Graham GG; Day RO
J Rheumatol; 2009 Dec; 36(12):2842-3; author reply 2844. PubMed ID: 19966196
[No Abstract] [Full Text] [Related]
57. Familial juvenile hyperuricaemic nephropathy.
Puig JG; Torres RJ
QJM; 2003 Feb; 96(2):172-3. PubMed ID: 12589017
[No Abstract] [Full Text] [Related]
58. [Hyperuricemia and gout].
Hosoya T
Nihon Naika Gakkai Zasshi; 2005 May; 94(5):886-90. PubMed ID: 15926456
[No Abstract] [Full Text] [Related]
59. What do epidemiologic studies tell us about hyperuricemia and cardiovascular disease and death?
Wu CW; Terkeltaub R
Curr Rheumatol Rep; 2005 Jun; 7(3):211-2. PubMed ID: 15918997
[No Abstract] [Full Text] [Related]
60. Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?
Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
Curr Vasc Pharmacol; 2011 Nov; 9(6):698-705. PubMed ID: 21388346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
